Valeant gets an FDA OK for new pso­ri­a­sis drug bro­dalum­ab — but there’s a big catch

The FDA has come through with an ap­proval for Valeant’s pso­ri­a­sis drug bro­dalum­ab. But they’ve hob­bled it with a black box safe­ty warn­ing on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA